Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating activities:
Net income	$ 135.6	$ 113.3
Adjustments for items not affecting cash:
Depreciation and amortization	126.7	114.5
Stock-based compensation expense	15.6	15.6
Amortization of right-of-use assets	41.4	38.7
Other, net	3.4	0.1
Net changes in operating assets and liabilities	(98.6)	(125.4)
Net cash provided by operating activities	224.1	156.8
Investing activities:
Property, plant and equipment additions	(51.5)	(54.3)
Proceeds on disposition of property, plant and equipment	2.4	1.1
Intangible asset additions	(27.8)	(27.7)
Proceeds from repayments of loans receivable	1.0	1.4
Issuance of loans receivable	(2.8)	(22.1)
Other, net	(0.1)	(0.3)
Net cash used in investing activities	(78.8)	(101.9)
Financing activities:
Dividends paid	(66.5)	(62.1)
Proceeds from exercise of stock options	2.5	4.3
Payment of tax withholding related to vesting of share units	(22.2)	(15.2)
Net increase in short-term debt	144.3	34.5
Repayment of long-term debt	(12.8)	(1.0)
Repayment of finance lease and equipment financing obligations	(8.0)	(6.5)
Proceeds from equipment financing obligations	0.5	1.0
Acquisition of VeriTread non-controlling interests	(14.2)	0.0
Net cash provided by (used in) financing activities	23.6	(45.0)
Effect of changes in exchange rates on cash, cash equivalents, and restricted cash	(4.3)	3.1
Net increase in cash, cash equivalents, and restricted cash	164.6	13.0
Cash, cash equivalents, and restricted cash, beginning of period	694.8	708.8
Cash, cash equivalents, and restricted cash, end of period	$ 859.4	$ 721.8